REDHILL BIOPHARMA LTD-SP ADR (RDHL)       0.2294  +0 (+1.5%)

0.2294  +0 (+1.5%)

US7574681034 - ADR - After market: 0.2231 -0.01 (-2.75%)

REDHILL BIOPHARMA LTD-SP ADR0.2294

NASDAQ:RDHL (2/3/2023, 7:04:38 PM)+0 (+1.5%)

After market: 0.2231 -0.01 (-2.75%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Pharmaceuticals

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 11-07 2022-11-07/bmo Earnings (Next) 03-15 2023-03-15/amc
Ins Owners N/A Inst Owners 3.12%
Market Cap 20.92M Shares 91.20M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 82.86
IPO 02-01 2011-02-01

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

RDHL Daily chart

Company Profile

RedHill Biopharma Ltd. develops medicines for gastrointestinal and infectious diseases. The firm is focused on the commercialization in the United States (U.S.) of the GI-related products, Movantik (naloxegol),Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). A part form Company's pipeline consists of six therapeutic candidates RHB-204 dedicated to Nontuberculous mycobacterial (NTM) treatment, RHB-104 dedicated to Crohn's disease, RHB-102 antiemetic drug ondansetron, in development for multiple gastrointestinal indications, RHB-106 an oral capsule formulation for bowel preparation, Opaganib an inhibitor, administered orally, with anticancer, anti-inflammatory and anti-viral activities and RHB-107 inhibitor of serine proteases targeting multiple indications, including COVID-19, cancer, inflammatory lung diseases and gastrointestinal diseases.

Company Info

REDHILL BIOPHARMA LTD-SP ADR

21 Ha'arba'a St.

TEL AVIV-YAFO 64739

P: 97235413131.0

CEO: Dror Ben-Asher

Employees: 201

Website: https://www.redhillbio.com/

RDHL News

News Image9 days ago - ChartmillThese stocks are the most active in today's session

Let's have a look at the most active stocks in today's session.

News Image9 days ago - ChartmillFriday's session: gap up and gap down stocks

Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session.

News Image9 days ago - InvestorPlaceWhy Is GeneDx (WGS) Stock Down 8% Today?

GeneDx (WGS) stock is taking a beating on Friday after the company revealed a $150 million proposed public stock offering.

News Image9 days ago - InvestorPlaceWhy Is ContraFect (CFRX) Stock Down 23% Today?

ContraFect (CFRX) stock is falling on Friday after the company provided an update on its potential delisting from the Nasdaq Capital Market.

News Image9 days ago - ChartmillFriday's pre-market session: top gainers and losers

The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

News Image9 days ago - InvestorPlaceWhy Is Akanda (AKAN) Stock Up 31% Today?

Akanda (AKAN) stock is on the rise Friday as the company's shares continue a rally that started yesterday following an FDA update.

RDHL Twits

Here you can normally see the latest stock twits on RDHL, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example